Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
SSE
25.42
+0.45 (+1.80%)
Closed
Sep 18, 2026
Day's Range
25.0526.10
52 wk Range
24.7059.37
Financial Statements - 603392 - Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Revenue
1.81B▼ 19.0%
Net Income
-413.96M▼ 479.5%Net Margin -22.8%
EBITDA
-8.29M▼ 101.8%
Free Cash Flow
-715.41M▼ 34.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.81B | 2.24B | 5.51B | 11.18B | 5.75B | 2.35B |
| Cost of Goods | 921.82M | 759.04M | 792.12M | 1.17B | 817.71M | 442.14M |
| Gross Profit | 897.14M | 1.48B | 4.71B | 10.01B | 4.93B | 1.91B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -426.40M | 2.30M | 1.62B | 5.59B | 2.43B | 825.73M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -480.88M | 67.48M | 1.39B | 5.58B | 2.32B | 764.45M |
| Income Tax | -66.92M | -41.61M | 146.88M | 719.38M | 244.93M | 82.63M |
| Net Income | -413.96M | 109.09M | 1.24B | 4.86B | 2.07B | 681.81M |
| EPS Basic | -0.31 | 0.08 | 0.99 | 3.79 | 1.642857 | 0.566502 |
| EPS Diluted | -0.31 | 0.08 | 0.99 | 3.79 | 1.642857 | 0.566502 |
| Basic Shares Outstanding | 1.28B | 1.32B | 1.26B | 1.24B | 1.23B | 1.19B |
| Diluted Shares Outstanding | 1.28B | 1.32B | 1.26B | 1.24B | 1.23B | 1.19B |
| Ebit | -474.42M | 75.80M | 1.40B | 5.59B | 2.32B | 766.13M |
| Ebitda | -8.29M | 452.62M | 2.04B | 5.83B | 2.54B | 901.49M |
| Net Income Continuous Operations | -413.96M | 109.09M | 1.24B | 4.86B | 2.07B | 681.81M |
| Minority Interests | 15.69M | -2.85M | 1.17M | -127.50M | -57.74M | -4.81M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
